ACHL | Achilles Therapeutics plc Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.7056 - 0.7302
52 Week Range	0.6300 - 1.7600
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	18,813
Average Volume	43,522
Shares Outstanding	41,087,901
Market Cap	28,991,623
Sector	Healthcare
Industry	Biotechnology
IPO Date	2021-03-31

Valuation
Profitability
Growth
Health
P/E Ratio	-0.44
Forward P/E Ratio	N/A
EPS	-1.59
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	204
Country	UK
Website	ACHL

Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. It is also developing products for use in the treatment of head and neck squamous cell carcinoma, renal cell carcinoma, triple negative breast cancer, and bladder cancer. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. The company was founded in 2016 and is headquartered in London, the United Kingdom.

ACHL's peers: ASMB, SPRO, TIL, NLTX, NUVB, CTMX, NXTC, ADXN, ALGS, APTO, APVO, ASLN, ATHA, BLRX, BOLT, CHRS, CKPT, CMRX, CNTB, CYCN, DSGN, FBIO, FBIOP, GLMD, GLPG, GLYC, KRON, KZIA, LVTX, LYRA, MBIO, MEIP, MESO, MTNB, NKTR, NLSP, OCUL, ORGS, OVID, PIRS, PRQR, PULM, TBPH, TCRT, XOMA, QNCX, DOMH

*Chart delayed

Analyzing fundamentals for ACHL we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see ACHL Fundamentals page.

Watching at ACHL technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on ACHL Technicals page.